Carbon C 11 alpha-methyltryptophan

OTHER2 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, Barbara Ann Karmanos Cancer Institute

Conditions

Breast CancerCarcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm

Phase 2

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

CompletedNCT03453489

Barbara Ann Karmanos Cancer InstituteCarcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm

Start: 2018-06-20End: 2020-10-15Updated: 2025-04-10

Unknown Phase

C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer

WithdrawnNCT01302821

H. Lee Moffitt Cancer Center and Research InstituteBreast Cancer

Start: 2013-01-31End: 2014-12-31Updated: 2017-02-23